An Open-Label, Single-Arm, Phase 2 Trial of Valemetostat in Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma.
Blood. 2022 Sep 23:blood.2022016862. doi: 10.1182/blood.2022016862. Online ahead of print.
Blood. 2022.
PMID: 36150143
Free article.